KALA KALA BIO, Inc.: institutional ownership and insider trading
14 funds reported holding $1.21M of KALA BIO, Inc. in their latest 13F filings; in Q2 2026 funds net bought $1.21M, with 14 new positions and 0 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of KALA
- VANGUARD CAPITAL MANAGEMENT LLC — $382K
- GEODE CAPITAL MANAGEMENT, LLC — $251K
- VANGUARD FIDUCIARY TRUST CO — $175K
- STATE STREET CORP (STT, STT-PG) — $153K
- BlackRock, Inc. (BLK) — $124K
- NORTHERN TRUST CORP (NTRS, NTRSO) — $72.0K
- Qube Research & Technologies Ltd — $19.2K
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $18.9K
- UBS Group AG (UBS) — $15.7K
- Tower Research Capital LLC (TRC) — $1.07K
Recent KALA insider trades
- Oct 23, 2025: Iwicki Mark T sold 154,894 shares ($125K)
- Oct 23, 2025: Reumuth Mary sold 33,197 shares ($27.5K)
- Oct 22, 2025: Brazzell Romulus K sold 46,748 shares ($38.8K)
- Oct 22, 2025: Bazemore Todd sold 47,768 shares ($39.6K)
5%+ owners
- Labkowski Nachum: 5.0% (Schedule 13G, filed Oct 19, 2026)